{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T02:13:59Z","timestamp":1793758439951,"version":"4.6.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070436"],"award-info":[{"award-number":["82070436"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["2020CFB234"],"award-info":[{"award-number":["2020CFB234"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.intimp.2021.108046","type":"journal-article","created":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T12:34:04Z","timestamp":1628598844000},"page":"108046","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"special_numbering":"C","title":["Selective Inhibition of NLRP3 Inflammasome Reverses Pressure Overload-Induced Pathological Cardiac Remodeling by Attenuating Hypertrophy, Fibrosis, and Inflammation"],"prefix":"10.1016","volume":"99","author":[{"given":"Mengmeng","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jishou","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongqi","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuwan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menglong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4865-783X","authenticated-orcid":false,"given":"Jun","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.intimp.2021.108046_b0005","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/oxfordjournals.eurheartj.a015268","article-title":"Upregulation of cell adhesion molecules and the presence of low grade inflammation in human chronic heart failure","volume":"18","author":"Devaux","year":"1997","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.intimp.2021.108046_b0010","doi-asserted-by":"crossref","first-page":"H1253","DOI":"10.1152\/ajpheart.00578.2001","article-title":"Alterations of beta-adrenergic signaling and cardiac hypertrophy in transgenic mice overexpressing TGF-beta(1)","volume":"283","author":"Rosenkranz","year":"2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"4","key":"10.1016\/j.intimp.2021.108046_b0015","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1161\/01.RES.81.4.627","article-title":"Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha","volume":"81","author":"Kubota","year":"1997","journal-title":"Circ Res"},{"issue":"11","key":"10.1016\/j.intimp.2021.108046_b0020","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1161\/CIRCULATIONAHA.106.643585","article-title":"Tumor necrosis factor-alpha mediates cardiac remodeling and ventricular dysfunction after pressure overload state","volume":"115","author":"Sun","year":"2007","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.intimp.2021.108046_b0025","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1161\/HYPERTENSIONAHA.109.148635","article-title":"Interleukin 6 mediates myocardial fibrosis, concentric hypertrophy, and diastolic dysfunction in rats","volume":"56","author":"Mel\u00e9ndez","year":"2010","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.intimp.2021.108046_b0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035144","article-title":"Macrophage-stimulated cardiac fibroblast production of IL-6 is essential for TGF \u03b2\/Smad activation and cardiac fibrosis induced by angiotensin II","volume":"7","author":"Ma","year":"2012","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.intimp.2021.108046_b0035","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1161\/CIRCRESAHA.109.208199","article-title":"Pressure-mediated hypertrophy and mechanical stretch induces IL-1 release and subsequent IGF-1 generation to maintain compensative hypertrophy by affecting Akt and JNK pathways","volume":"105","author":"Honsho","year":"2009","journal-title":"Circ Res"},{"issue":"3","key":"10.1016\/j.intimp.2021.108046_b0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033438","article-title":"Enhanced interleukin-1 activity contributes to exercise intolerance in patients with systolic heart failure","volume":"7","author":"Van Tassell","year":"2012","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.intimp.2021.108046_b0045","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1161\/CIRCULATIONAHA.118.038010","article-title":"Anti-Inflammatory Therapy With Canakinumab for the Prevention of Hospitalization for Heart Failure","volume":"139","author":"Everett","year":"2019","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.intimp.2021.108046_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108405","article-title":"RACK1 Mediates NLRP3 Inflammasome Activation by Promoting NLRP3 Active Conformation and Inflammasome Assembly","volume":"33","author":"Duan","year":"2020","journal-title":"Cell Rep"},{"issue":"8","key":"10.1016\/j.intimp.2021.108046_b0055","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/nrd.2018.97","article-title":"Targeting the NLRP3 inflammasome in inflammatory diseases","volume":"17","author":"Mangan","year":"2018","journal-title":"Nat Rev Drug Discov"},{"issue":"7575","key":"10.1016\/j.intimp.2021.108046_b0060","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/nature15514","article-title":"Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death","volume":"526","author":"Shi","year":"2015","journal-title":"Nature"},{"issue":"13","key":"10.1016\/j.intimp.2021.108046_b0065","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20133328","article-title":"The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation","volume":"20","author":"Kelley","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"12","key":"10.1016\/j.intimp.2021.108046_b0070","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1161\/CIRCULATIONAHA.119.042336","article-title":"SNO-MLP (S-Nitrosylation of Muscle LIM Protein) Facilitates Myocardial Hypertrophy Through TLR3 (Toll-Like Receptor 3)-Mediated RIP3 (Receptor-Interacting Protein Kinase 3) and NLRP3 (NOD-Like Receptor Pyrin Domain Containing 3) Inflammasome Activation","volume":"141","author":"Tang","year":"2020","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.intimp.2021.108046_b0075","first-page":"5332","article-title":"Astragaloside IV prevents myocardial hypertrophy induced by mechanical stress by activating autophagy and reducing inflammation","volume":"12","author":"Zhang","year":"2020","journal-title":"Am J Transl Res"},{"issue":"2","key":"10.1016\/j.intimp.2021.108046_b0080","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20020360","article-title":"Dual Role of Triptolide in Interrupting the NLRP3 Inflammasome Pathway to Attenuate Cardiac Fibrosis","volume":"20","author":"Pan","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.intimp.2021.108046_b0085","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s10557-020-06995-x","article-title":"Protection of Sacubitril\/Valsartan against Pathological Cardiac Remodeling by Inhibiting the NLRP3 Inflammasome after Relief of Pressure Overload in Mice","volume":"34","author":"Li","year":"2020","journal-title":"Cardiovasc Drugs Ther"},{"issue":"1","key":"10.1016\/j.intimp.2021.108046_b0090","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.bbrc.2017.02.021","article-title":"Triptolide attenuates pressure overload-induced myocardial remodeling in mice via the inhibition of NLRP3 inflammasome expression","volume":"485","author":"Li","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.intimp.2021.108046_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.04.022","article-title":"The selective NLRP3-inflammasome inhibitor MCC950 reduces myocardial fibrosis and improves cardiac remodeling in a mouse model of myocardial infarction","volume":"74","author":"Gao","year":"2019","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.intimp.2021.108046_b0100","article-title":"(18)F-FDG PET imaging-monitored anti-inflammatory therapy for acute myocardial infarction: Exploring the role of MCC950 in murine model","author":"Li","year":"2020","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.intimp.2021.108046_b0105","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ebiom.2018.08.022","article-title":"TRPA1 inhibition ameliorates pressure overload-induced cardiac hypertrophy and fibrosis in mice","volume":"36","author":"Wang","year":"2018","journal-title":"EBioMedicine"},{"issue":"13","key":"10.1016\/j.intimp.2021.108046_b0110","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1161\/CIRCULATIONAHA.115.020502","article-title":"Drp1-Dependent Mitochondrial Autophagy Plays a Protective Role Against Pressure Overload-Induced Mitochondrial Dysfunction and Heart Failure","volume":"133","author":"Shirakabe","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.intimp.2021.108046_b0115","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.yjmcc.2016.06.001","article-title":"Physiological and pathological cardiac hypertrophy","volume":"97","author":"Shimizu","year":"2016","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.intimp.2021.108046_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.112660","article-title":"Songling Xuemaikang Capsule inhibits isoproterenol-induced cardiac hypertrophy via CaMKII\u03b4 and ERK1\/2 pathways","volume":"253","author":"Qi","year":"2020","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.intimp.2021.108046_b0125","article-title":"Imaging Interstitial Fibrosis, Left Ventricular Remodeling, and Function in Stage A and B Heart Failure","author":"Pezel","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"issue":"8","key":"10.1016\/j.intimp.2021.108046_b0130","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1631\/jzus.2006.B0641","article-title":"Bone marrow mesenchymal stem cell transplantation combined with perindopril treatment attenuates infarction remodelling in a rat model of acute myocardial infarction","volume":"7","author":"Wang","year":"2006","journal-title":"J Zhejiang Univ Sci B"},{"issue":"12","key":"10.1016\/j.intimp.2021.108046_b0135","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/nri2448","article-title":"Exploring the full spectrum of macrophage activation","volume":"8","author":"Mosser","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.intimp.2021.108046_b0140","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ebiom.2018.06.009","article-title":"Interleukin-12p35 Knock Out Aggravates Doxorubicin-Induced Cardiac Injury and Dysfunction by Aggravating the Inflammatory Response Oxidative Stress, Apoptosis and Autophagy in Mice","volume":"35","author":"Ye","year":"2018","journal-title":"EBioMedicine"},{"issue":"22","key":"10.1016\/j.intimp.2021.108046_b0145","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1161\/CIRCULATIONAHA.118.034621","article-title":"Inflammation and NLRP3 Inflammasome Activation Initiated in Response to Pressure Overload by Ca(2+)\/Calmodulin-Dependent Protein Kinase II \u03b4 Signaling in Cardiomyocytes Are Essential for Adverse Cardiac Remodeling","volume":"138","author":"Suetomi","year":"2018","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.intimp.2021.108046_b0150","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s00011-018-1160-9","article-title":"sRAGE attenuates angiotensin II-induced cardiomyocyte hypertrophy by inhibiting RAGE-NF\u03baB-NLRP3 activation","volume":"67","author":"Lim","year":"2018","journal-title":"Inflamm Res"},{"issue":"7","key":"10.1016\/j.intimp.2021.108046_b0155","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1161\/CIRCRESAHA.116.302317","article-title":"Innate immunity and the failing heart: the cytokine hypothesis revisited","volume":"116","author":"Mann","year":"2015","journal-title":"Circulation research"},{"issue":"7","key":"10.1016\/j.intimp.2021.108046_b0160","doi-asserted-by":"crossref","first-page":"H1025","DOI":"10.1152\/ajpheart.00795.2013","article-title":"Interleukin-18 mediates interleukin-1-induced cardiac dysfunction","volume":"306","author":"Toldo","year":"2014","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"6","key":"10.1016\/j.intimp.2021.108046_b0165","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000267","article-title":"Toll-like receptor-2 mediates adaptive cardiac hypertrophy in response to pressure overload through interleukin-1\u03b2 upregulation via nuclear factor \u03baB activation","volume":"2","author":"Higashikuni","year":"2013","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"10.1016\/j.intimp.2021.108046_b0170","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1023\/A:1011428824771","article-title":"The role of interleukin-1 in the failing heart","volume":"6","author":"Long","year":"2001","journal-title":"Heart Fail Rev"},{"issue":"22","key":"10.1016\/j.intimp.2021.108046_b0175","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1093\/eurheartj\/ehy128","article-title":"Interleukin-1 blockade in cardiovascular diseases: a clinical update","volume":"39","author":"Buckley","year":"2018","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.intimp.2021.108046_b0180","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1536\/ihj.17-565","article-title":"Chronic Pressure Overload Induces Cardiac Hypertrophy and Fibrosis via Increases in SGLT1 and IL-18 Gene Expression in Mice","volume":"59","author":"Matsushita","year":"2018","journal-title":"Int Heart J"},{"issue":"1","key":"10.1016\/j.intimp.2021.108046_b0185","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.cyto.2010.10.002","article-title":"Effects of interleukin-18 on cardiac fibroblast function and gene expression","volume":"53","author":"Fix","year":"2011","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.intimp.2021.108046_b0190","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/eurheartj\/ehx261","article-title":"IL-18 cleavage triggers cardiac inflammation and fibrosis upon \u03b2-adrenergic insult","volume":"39","author":"Xiao","year":"2018","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.intimp.2021.108046_b0195","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/01.shk.0000226341.32786.b9","article-title":"Jak\/STAT\/SOCS signaling circuits and associated cytokine-mediated inflammation and hypertrophy in the heart","volume":"26","author":"Terrell","year":"2006","journal-title":"Shock"},{"issue":"4","key":"10.1016\/j.intimp.2021.108046_b0200","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.ajpath.2014.11.027","article-title":"Nonclassical resident macrophages are important determinants in the development of myocardial fibrosis","volume":"185","author":"Falkenham","year":"2015","journal-title":"Am J Pathol"},{"key":"10.1016\/j.intimp.2021.108046_b0205","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ijcard.2015.10.126","article-title":"Macrophages dictate the progression and manifestation of hypertensive heart disease","volume":"203","author":"Kain","year":"2016","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.intimp.2021.108046_b0210","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.immuni.2013.11.019","article-title":"Embryonic and adult-derived resident cardiac macrophages are maintained through distinct mechanisms at steady state and during inflammation","volume":"40","author":"Epelman","year":"2014","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.intimp.2021.108046_b0215","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1172\/JCI45444","article-title":"Kr\u00fcppel-like factor 4 regulates macrophage polarization","volume":"121","author":"Liao","year":"2011","journal-title":"J Clin Invest"},{"issue":"7","key":"10.1016\/j.intimp.2021.108046_b0220","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1161\/ATVBAHA.112.248732","article-title":"Serum-glucocorticoid regulated kinase 1 regulates alternatively activated macrophage polarization contributing to angiotensin II-induced inflammation and cardiac fibrosis","volume":"32","author":"Yang","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"7","key":"10.1016\/j.intimp.2021.108046_b0225","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1161\/ATVBAHA.112.249706","article-title":"Interleukin-12p35 deletion promotes CD4 T-cell-dependent macrophage differentiation and enhances angiotensin II-Induced cardiac fibrosis","volume":"32","author":"Li","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.intimp.2021.108046_b0230","first-page":"265","article-title":"Luteolin alleviates NLRP3 inflammasome activation and directs macrophage polarization in lipopolysaccharide-stimulated RAW264.7 cells","volume":"10","author":"Zhang","year":"2018","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.intimp.2021.108046_b0235","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3389\/fncel.2019.00553","article-title":"Meisoindigo Protects Against Focal Cerebral Ischemia-Reperfusion Injury by Inhibiting NLRP3 Inflammasome Activation and Regulating Microglia\/Macrophage Polarization via TLR4\/NF-\u03baB Signaling Pathway","volume":"13","author":"Ye","year":"2019","journal-title":"Front Cell Neurosci"},{"issue":"4","key":"10.1016\/j.intimp.2021.108046_b0240","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/jcpe.13258","article-title":"NLRP3 inflammasome mediates M1 macrophage polarization and IL-1\u03b2 production in inflammatory root resorption","volume":"47","author":"Zhang","year":"2020","journal-title":"J Clin Periodontol"},{"issue":"12","key":"10.1016\/j.intimp.2021.108046_b0245","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1042\/BCJ20180086","article-title":"NLRP3 regulates macrophage M2 polarization through up-regulation of IL-4 in asthma","volume":"475","author":"Liu","year":"2018","journal-title":"Biochem J"},{"issue":"3","key":"10.1016\/j.intimp.2021.108046_b0250","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1172\/JCI59643","article-title":"Macrophage plasticity and polarization: in vivo veritas","volume":"122","author":"Sica","year":"2012","journal-title":"The Journal of clinical investigation"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921006822?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921006822?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T20:15:48Z","timestamp":1730837748000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576921006822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":50,"alternative-id":["S1567576921006822"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2021.108046","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selective Inhibition of NLRP3 Inflammasome Reverses Pressure Overload-Induced Pathological Cardiac Remodeling by Attenuating Hypertrophy, Fibrosis, and Inflammation","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2021.108046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108046"}}